Patients without prior antihypertensive treatment or who had discontinued antihypertensive agents for two weeks were randomly assigned to the morning (6 a.m. to 10 a.m.) or bedtime (6 p.m. to 10 p.m.) ...

They were randomly assigned to receive a daily single-pill combination of olmesartan (20 mg) and amlodipine (5 mg) either in the morning (6:00-10:00 am; n=352) or at bedtime (6:00-10:00 pm; n=368) for ...

WEDNESDAY, July 16, 2025 (HealthDay News) -- Bedtime dosing with antihypertensive medication yields better nocturnal blood pressure control and improved circadian rhythm, according to a study ...

Bedtime dosing of antihypertensive medication provided better control of nocturnal blood pressure and improved circadian rhythm without reducing efficacy of treatment.

OTTAWA, ON, July 5, 2025 /CNW/ – Summary Affected products Issue Nora Pharma is recalling one lot of NRA-Amlodipine 5 mg tablets because some bottles may… ...

Nora Pharma is recalling one lot of NRA-Amlodipine 5 mg tablets because some bottles may contain the wrong tablets, which have been identified as metoprolol succinate prolonged–release 12.5 mg ...

Nora Pharma is recalling one lot of NRA-Amlodipine 5 mg tablets because some bottles may contain the wrong tablets, which have been identified as metoprolol succinate prolonged–release 12.5 mg tablets ...

WIDAPLIK is a proprietary single pill combination of three medicines: telmisartan, amlodipine and indapamide and is available in three doses: a standard dose and two low doses. It is the first and ...

Federal regulators have accepted Novo Nordisk’s application to produce a pill version of its injectable weight-loss medication Wegovy. Experts say an oral medication for weight loss might be ...